Shares of Tenet Healthcare (NYSE:THC) fell in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 26.19% over the past year to $1.59, which beat the estimate of $1.07.
Revenue of $4,954,000,000 higher by 35.80% year over year, which beat the estimate of $4,780,000,000.
Looking Ahead
Tenet Sees Q3 Sales $4.6B-$4.8B vs $4.88B Est., Adj. EPS $0.73-$1.06 vs $1.06 Est.
Tenet Sees FY21 Sales $19.25B-$19.65B vs $19.61B Est.
Price Action
Company's 52-week high was at $71.75
52-week low: $21.34
Price action over last quarter: Up 23.33%
Company Profile
Tenet Healthcare is a Dallas-based healthcare provider organization operating a collection of hospitals (65) and many outpatient facilities, including ambulatory surgery centers, urgent care centers, freestanding imaging centers, freestanding emergency rooms/micro-hospitals, and physician practices across the United States. Tenet enjoys the number-one ambulatory surgical center position nationwide through its nearly full stake in United Surgical Partners International.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
